Cabaletta Bio, Inc. (CABA)
Company Info
| ISIN | US12674W1099 |
|---|---|
| CUSIP | 12674W109 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $543.28M |
|---|---|
| EPS | -$1.65 |
| EBITDA (TTM) | -$73.23M |
| Year Range | $9.02 - $26.35 |
| Target Price | $34.11 |
| Short % | 21.95% |
| Short Ratio | 7.72 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: CABA vs. CATH, CABA vs. OLMA
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Cabaletta Bio, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Cabaletta Bio, Inc. had a return of -44.10% year-to-date (YTD) and -3.57% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -44.10% | 11.29% |
| 1 month | -21.57% | 4.87% |
| 6 months | -26.94% | 17.88% |
| 1 year | -3.57% | 29.16% |
| 5 years (annualized) | N/A | 13.20% |
| 10 years (annualized) | N/A | 10.97% |
Monthly Returns
The table below presents the monthly returns of CABA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -9.78% | 11.72% | -25.44% | -37.60% | -44.10% | ||||||||
| 2023 | 31.78% | -27.48% | -6.45% | 25.51% | -2.79% | 27.95% | 5.50% | 3.96% | 7.49% | -6.31% | 12.55% | 41.43% | 145.41% |
| 2022 | -20.32% | -28.48% | -6.02% | -32.02% | -7.25% | -17.19% | 11.32% | -19.07% | -31.94% | 160.00% | 165.09% | 106.47% | 144.06% |
| 2021 | 4.41% | -16.58% | 2.12% | 0.27% | 1.89% | -24.16% | -13.26% | 36.46% | 19.45% | 12.42% | -15.29% | -67.27% | -69.63% |
| 2020 | 17.61% | -9.07% | -51.14% | -0.68% | 17.93% | 30.29% | 2.60% | -7.70% | 2.75% | 6.73% | 28.61% | -16.13% | -10.67% |
| 2019 | 5.00% | 30.48% | 1.97% | 39.70% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of CABA is 51, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
CABA (Cabaletta Bio, Inc.)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Cabaletta Bio, Inc. (CABA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Cabaletta Bio, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Cabaletta Bio, Inc. was 96.63%, occurring on Sep 23, 2022. Recovery took 294 trading sessions.
The current Cabaletta Bio, Inc. drawdown is 50.00%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.63% | Jan 30, 2020 | 669 | Sep 23, 2022 | 294 | Nov 24, 2023 | 963 |
| -58.71% | Feb 9, 2024 | 55 | Apr 29, 2024 | — | — | — |
| -55.51% | Nov 20, 2019 | 16 | Dec 12, 2019 | 31 | Jan 29, 2020 | 47 |
| -26.79% | Nov 28, 2023 | 1 | Nov 28, 2023 | 11 | Dec 13, 2023 | 12 |
| -19.64% | Jan 9, 2024 | 8 | Jan 19, 2024 | 14 | Feb 8, 2024 | 22 |
Volatility
Volatility Chart
The current Cabaletta Bio, Inc. volatility is 28.73%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |